Article summary
The Competition and Markets Authority (CMA) has published the full text of its phase 1 decision in relation to the anticipated acquisition by AstraZeneca plc of Alexion Pharmaceuticals, Inc.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial